{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:25:50Z","timestamp":1773422750946,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T00:00:00Z","timestamp":1674259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T00:00:00Z","timestamp":1674259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s11596-022-2652-y","type":"journal-article","created":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T08:02:46Z","timestamp":1674288166000},"page":"22-34","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Optimization of the Process for Preparing Bivalent Polysaccharide Conjugates to Develop Multivalent Conjugate Vaccines against Streptococcus pneumoniae or Neisseria meningitidis and Comparison with the Corresponding Licensed Vaccines in Animal Models"],"prefix":"10.1007","volume":"43","author":[{"given":"Fang","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-bing","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin-bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-rong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,21]]},"reference":[{"issue":"1","key":"2652_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1517\/14712598.2012.725718","volume":"13","author":"D Pace","year":"2013","unstructured":"Pace D. Glycoconjugate vaccines. Expert Opin Biol Ther, 2013,13(1):11\u201333","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"2652_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/14712598.2018.1384462","volume":"18","author":"N Principi","year":"2018","unstructured":"Principi N, Esposito S. Development of pneumococcal vaccines over the last 10 years. Expert Opin Biol Ther, 2018,18(1):7\u201317","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"2652_CR3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/vaccines8010132","volume":"8","author":"M Masomian","year":"2020","unstructured":"Masomian M, Ahmad Z, Gew LT, et al. Development of Next Generation Streptococcus pneumoniae Vaccines Conferring Broad Protection. Vaccines. 2020,8(1):132","journal-title":"Vaccines"},{"issue":"1","key":"2652_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3934\/publichealth.2020004","volume":"7","author":"G Oligbu","year":"2020","unstructured":"Oligbu G. Higher Valent Pneumococcal Conjugate Vaccines: is it a roller coaster? AIMS Public Health, 2020,7(1):29\u201332","journal-title":"AIMS Public Health"},{"issue":"2","key":"2652_CR5","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jadohealth.2016.04.012","volume":"59","author":"SI Pelton","year":"2016","unstructured":"Pelton SI. The Global Evolution of Meningococcal Epidemiology Following the Introduction of Meningococcal Vaccines. J Adolesc Health, 2016,59(2, Supplement):S3\u2013S11","journal-title":"J Adolesc Health"},{"issue":"9","key":"2652_CR6","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s10719-014-9559-1","volume":"31","author":"R Adamo","year":"2014","unstructured":"Adamo R, Nilo A, Harfouche C, et al. Investigating the immunodominance of carbohydrate antigens in a bivalent unimolecular glycoconjugate vaccine against serogroup A and C meningococcal disease. Glycoconjugate J, 2014,31(9):637\u2013647","journal-title":"Glycoconjugate J"},{"issue":"9","key":"2652_CR7","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1039\/C7SC05467J","volume":"9","author":"Y M\u00e9ndez","year":"2018","unstructured":"M\u00e9ndez Y, Chang J, Humpierre AR, et al. Multicomponent polysaccharide\u2014protein bioconjugation in the development of antibacterial glycoconjugate vaccine candidates. Chem Sci, 2018,9(9):2581\u20132588","journal-title":"Chem Sci"},{"issue":"9","key":"2652_CR8","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1021\/acs.bioconjchem.0c00423","volume":"31","author":"AR Humpierre","year":"2020","unstructured":"Humpierre AR, Zanuy A, Saenz M, et al. Expanding the Scope of Ugi Multicomponent Bioconjugation to Produce Pneumococcal Multivalent Glycoconjugates as Vaccine Candidates. Bioconjugate Chem, 2020,31(9): 2231\u20132240","journal-title":"Bioconjugate Chem"},{"issue":"3","key":"2652_CR9","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/0264-410X(95)00195-7","volume":"14","author":"A Lees","year":"1996","unstructured":"Lees A, Nelson BL, Mond JJ. Activation of soluble polysaccharides with 1-cyano-4-dimethy-laminopyridinium tetrafluoroborate for use in protein\u2014polysaccharide conjugate vaccines and immunological reagents. Vaccine, 1996,14(3):190\u2013198","journal-title":"Vaccine"},{"issue":"1","key":"2652_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1128\/iai.40.1.245-256.1983","volume":"40","author":"C Chu","year":"1983","unstructured":"Chu C, Schneerson R, Robbins JB, et al. Further Studies on the Immunogenicity of Haemophilus influenzae Type b and Pneumococcal Type 6A Polysaccharide-Protein Conjugates. Infect Immun, 1983,40(1):245\u2013256","journal-title":"Infect Immun"},{"issue":"45","key":"2652_CR11","doi-asserted-by":"publisher","first-page":"6409","DOI":"10.1016\/j.vaccine.2012.08.021","volume":"30","author":"F Berti","year":"2012","unstructured":"Berti F, Romano MR, Micoli F, et al. Relative stability of meningococcal serogroup A and X polysaccharides. Vaccine, 2012,30(45):6409\u20136415","journal-title":"Vaccine"},{"issue":"42","key":"2652_CR12","doi-asserted-by":"publisher","first-page":"6201","DOI":"10.1016\/j.vaccine.2019.08.048","volume":"37","author":"A Thompson","year":"2019","unstructured":"Thompson A, Lamberth E, Severs J, et al. Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults. Vaccine, 2019,37(42):6201\u20136207","journal-title":"Vaccine"},{"issue":"33","key":"2652_CR13","doi-asserted-by":"publisher","first-page":"6164","DOI":"10.1016\/j.vaccine.2007.06.004","volume":"25","author":"DA Scott","year":"2007","unstructured":"Scott DA, Komjathy SF, Hu BT, et al. Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults. Vaccine, 2007,25(33):6164\u20136166","journal-title":"Vaccine"},{"key":"2652_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.coi.2020.03.015","volume":"65","author":"F Berti","year":"2020","unstructured":"Berti F, Micoli F. Improving efficacy of glycoconjugate vaccines: from chemical conjugates to next generation constructs. Curr Opin Immunol, 2020,65:42\u201349","journal-title":"Curr Opin Immunol"},{"issue":"7","key":"2652_CR15","first-page":"1808","volume":"12","author":"M Br\u00f6ker","year":"2016","unstructured":"Br\u00f6ker M, Berti F, Costantino P. Factors contributing to the immunogenicity of meningococcal conjugate vaccines. Hum Vacc Immunother, 2016, 12(7):1808\u20131824","journal-title":"Hum Vacc Immunother"},{"key":"2652_CR16","doi-asserted-by":"crossref","unstructured":"Biemans R, Micoli F, Romano MR. 8-Glycoconjugate vaccines, production and characterization. In: Rauter AP, BE Christensen, L Soms\u00e1k, et al., eds. Recent Trends in Carbohydrate Chemistry: Elsevier, 2020:285\u2013313","DOI":"10.1016\/B978-0-12-820954-7.00008-6"},{"issue":"5","key":"2652_CR17","doi-asserted-by":"publisher","first-page":"e00520","DOI":"10.1128\/mSphere.00520-19","volume":"4","author":"F Avci","year":"2019","unstructured":"Avci F, Berti F, Dull P, et al. Glycoconjugates: What It Would Take To Master These Well-Known yet Little-Understood Immunogens for Vaccine Development. mSphere, 2019,4(5):e00520\u201300519","journal-title":"mSphere"},{"issue":"9","key":"2652_CR18","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1080\/14760584.2019.1657012","volume":"18","author":"F Micoli","year":"2019","unstructured":"Micoli F, Del Bino L, Alfini R, et al. Glycoconjugate vaccines: current approaches towards faster vaccine design. Expert Rev Vaccines, 2019,18(9):881\u2013895","journal-title":"Expert Rev Vaccines"},{"issue":"23","key":"2652_CR19","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1016\/j.vaccine.2015.04.031","volume":"33","author":"R Rana","year":"2015","unstructured":"Rana R, Dalal J, Singh D, et al. Development and characterization of Haemophilus influenzae type b conjugate vaccine prepared using different polysacc-haride chain lengths. Vaccine, 2015,33(23):2646\u20132654","journal-title":"Vaccine"},{"issue":"13","key":"2652_CR20","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1016\/j.vaccine.2020.02.012","volume":"38","author":"K Lockyer","year":"2020","unstructured":"Lockyer K, Gao F, Francis RJ, et al. Higher mass meningococcal group C-tetanus toxoid vaccines conjugated with carbodiimide correlate with greater immunogenicity. Vaccine, 2020,38(13):2859\u20132869","journal-title":"Vaccine"},{"issue":"6","key":"2652_CR21","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1128\/IAI.66.6.2441-2446.1998","volume":"66","author":"CA Laferriere","year":"1998","unstructured":"Laferriere CA, Sood RK, De Muys JM, et al. Streptococcus pneumoniae Type 14 Polysaccharide-Conjugate Vaccines: Length Stabilization of Opsono-phagocytic Conformational Polysaccharide Epitopes. Infect Immun, 1998,66(6):2441\u20132446","journal-title":"Infect Immun"},{"issue":"2","key":"2652_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0264-410X(96)00148-X","volume":"15","author":"CA Laferri\u00e8re","year":"1997","unstructured":"Laferri\u00e8re CA, Sood RK, De Muys J-M, et al. The synthesis of Streptococcus pneumoniae polysaccharide-tetanus toxoid conjugates and the effect of chain length on immunogenicity. Vaccine, 1997,15(2):179\u2013186","journal-title":"Vaccine"},{"issue":"52","key":"2652_CR23","doi-asserted-by":"publisher","first-page":"13353","DOI":"10.1073\/pnas.1811862115","volume":"115","author":"P Kaplonek","year":"2018","unstructured":"Kaplonek P, Khan N, Reppe K, et al. Improving vaccines against Streptococcus pneumoniae using synthetic glycans. Proc Natl Acad Sci, 2018, 115(52):13353\u201313358","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"2652_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1021\/acscentsci.7b00504","volume":"4","author":"B Schumann","year":"2018","unstructured":"Schumann B, Reppe K, Kaplonek P, et al. Development of an Efficacious, Semisynthetic Glycoconjugate Vaccine Candidate against Streptococcus pneumoniae Serotype 1. ACS Cent Sci, 2018,4(3):357\u2013361","journal-title":"ACS Cent Sci"},{"key":"2652_CR25","doi-asserted-by":"publisher","first-page":"108277","DOI":"10.1016\/j.carres.2021.108277","volume":"502","author":"Javed","year":"2021","unstructured":"Javed, Mandal PK. Bacterial surface capsular polysaccharides from Streptococcus pneumoniae: A systematic review on structures, syntheses, and glycoconjugate vaccines. Carbohydr Res, 2021,502: 108277","journal-title":"Carbohydr Res"},{"issue":"2","key":"2652_CR26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1084\/jem.152.2.361","volume":"152","author":"R Schneerson","year":"1980","unstructured":"Schneerson R, Barrera O, Sutton A, et al. Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates. J Exp Med, 1980,152(2):361\u2013376","journal-title":"J Exp Med"},{"issue":"46","key":"2652_CR27","doi-asserted-by":"publisher","first-page":"6468","DOI":"10.1016\/j.vaccine.2009.06.013","volume":"27","author":"CE Frasch","year":"2009","unstructured":"Frasch CE. Preparation of bacterial polysaccharide\u2014protein conjugates: Analytical and manufacturing challenges. Vaccine, 2009,27(46):6468\u20136470","journal-title":"Vaccine"},{"issue":"9","key":"2652_CR28","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.1128\/IAI.71.9.5115-5120.2003","volume":"71","author":"Z Jin","year":"2003","unstructured":"Jin Z, Chu C, Robbins JB, et al. Preparation and Characterization of Group A Meningococcal Capsular Polysaccharide Conjugates and Evaluation of Their Immunogenicity in Mice. Infect Immun, 2003,71(9):5115\u20135120","journal-title":"Infect Immun"},{"issue":"12","key":"2652_CR29","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/nm.2535","volume":"17","author":"FY Avci","year":"2011","unstructured":"Avci FY, Li X, Tsuji M, et al. A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design. Nat Med, 2011,17(12):1602\u20131609","journal-title":"Nat Med"},{"issue":"34","key":"2652_CR30","doi-asserted-by":"publisher","first-page":"5513","DOI":"10.1016\/j.vaccine.2010.06.026","volume":"28","author":"R Dagan","year":"2010","unstructured":"Dagan R, Poolman J, Siegrist CA. Glycoconjugate vaccines and immune interference: A review. Vaccine, 2010,28(34):5513\u20135523","journal-title":"Vaccine"},{"issue":"2","key":"2652_CR31","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.celrep.2018.09.029","volume":"25","author":"MC Woodruff","year":"2018","unstructured":"Woodruff MC, Kim EH, Luo W, et al. B Cell Competition for Restricted T Cell Help Suppresses Rare-Epitope Responses. Cell Rep, 2018,25(2):321\u2013327.e323","journal-title":"Cell Rep"},{"issue":"2","key":"2652_CR32","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/S0264-410X(98)00162-5","volume":"17","author":"A Fattom","year":"1999","unstructured":"Fattom A, Cho YH, Chu C, et al. Epitopic overload at the site of injection may result in suppression of the immune response to combined capsular polysaccharide conjugate vaccines. Vaccine, 1999,17(2):126\u2013133","journal-title":"Vaccine"},{"issue":"4","key":"2652_CR33","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0161-5890(86)90136-7","volume":"23","author":"M Porro","year":"1986","unstructured":"Porro M, Costantino P, Giovannoni F, et al. A molecular model of artificial glycoprotein with predetermined multiple immunodeterminants for gram-positive and gram-negative encapsulated bacteria. Mol Immunol, 1986,23(4):385\u2013391","journal-title":"Mol Immunol"},{"issue":"3","key":"2652_CR34","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1542\/peds.2009-3027","volume":"126","author":"SH Yeh","year":"2010","unstructured":"Yeh SH, Gurtman A, Hurley DC, et al. Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers. Pediatrics, 2010,126 (3):e493\u2013e505","journal-title":"Pediatrics"},{"issue":"7","key":"2652_CR35","first-page":"1","volume":"17","author":"D Fitz-Patrick","year":"2021","unstructured":"Fitz-Patrick D, Young Jr M, Scott DA, et al. Arandomized phase 1 study of the safety and immunogenicity of 2 novel pneumococcal conjugate vaccines in healthy Japanese adults in the United States. Hum Vacc Immunother, 2021,17(7):1\u20138","journal-title":"Hum Vacc Immunother"},{"issue":"6","key":"2652_CR36","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.vaccine.2016.12.055","volume":"35","author":"I Caro-Aguilar","year":"2017","unstructured":"Caro-Aguilar I, Indrawati L, Kaufhold RM, et al. Immunogenicity differences of a 15-valent pneumococcal polysaccharide conjugate vaccine (PCV15) based on vaccine dose, route of immunization and mouse strain. Vaccine, 2017,35(6):865\u2013872","journal-title":"Vaccine"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-022-2652-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-022-2652-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-022-2652-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:31:14Z","timestamp":1744158674000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-022-2652-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,21]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["2652"],"URL":"https:\/\/doi.org\/10.1007\/s11596-022-2652-y","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,21]]},"assertion":[{"value":"5 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}}]}}